Low-grade inflammation is associated with susceptibility to infection in healthy men: Results from the Danish Blood Donor study (DBDS)

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Kaspersen, Kathrine Agergård ^a   Dinh, Khoa Manh ^a   Erikstrup, Lise Tornvig ^a   Burgdorf, Kristoffer Sølvsten ^d   Pedersen, Ole Birger ^b   Sørensen, Erik ^d   Petersen, Mikkel Steen ^a   Hjalgrim, Henrik ^c   Rostgaard, Klaus ^c   Nielsen, Kaspar Rene ^e   Ullum, Henrik ^d   Erikstrup, Christian ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NAESTVED HOSPITAL   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CIPROFLOXACIN; CLARITHROMYCIN; DICLOXACILLIN; ERYTHROMYCIN; FLUCLOXACILLIN; NITROFURANTOIN; PENICILLIN V; PIVAMPICILLIN; PIVMECILLINAM; ROXITHROMYCIN; SULFAMETHIZOLE; TRIMETHOPRIM;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD DONOR; CHARLSON COMORBIDITY INDEX; CLINICAL PRACTICE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; HYPERTENSION; ICD-10; INFLAMMATION; LOW GRADE INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK FACTOR; SKIN INFECTION; TRANSCRIPTION REGULATION; URINARY TRACT INFECTION; ADOLESCENT; COMMUNICABLE DISEASES; COMPLICATION; DENMARK; HOSPITALIZATION; INTERNATIONAL CLASSIFICATION OF DISEASES; METABOLISM; MIDDLE AGED; SEXUAL DEVELOPMENT; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; C-REACTIVE PROTEIN; COMMUNICABLE DISEASES; DENMARK; DISEASE SUSCEPTIBILITY; FEMALE; HOSPITALIZATION; HUMANS; INFLAMMATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84991501135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164220     Document Type: Article

References (45)

1. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003 Jun; 111(12):1805-12. doi: 10.1172/jci200318921 PMID: 12813013
2. Du Clos TW. Function of C-reactive protein. Ann Med. 2000 May; 32(4):274-8. doi: 10.3109/07853890009011772 PMID: 10852144
3. Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin LabSci. 2011 Aug; 48(4):155-70. doi: 10.3109/10408363.2011.599831 PMID: 22035340
4. Hage FG, Szalai AJ. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol. 2007 Sep. 18;50(12):1115-22. doi: https://dx.doi.org/10. 1016/j.jacc.2007.06.012 PMID: 17868801
5. Nielen MMJ, van Schaardenburg D, Reesink HW, Twisk JWR, van de Stadt RJ, van der Horst-Bruinsma IE, et al. Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum. 2004 Aug; 50(8):2423-7. doi: https://dx.doi.org/10.1002/art. 20431 PMID: 15334453
6. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA J Am Med Assoc. 2003 Dec. 10;290(22):2945-51. doi: 10.1001/jama. 290.22.2945 PMID: 14665655
7. Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer J Int Cancer. 2008 Sep. 1;123(5):1133-40. doi: 10.1002/ijc.23606 PMID: 18528865
8. Imhof A, Frohlich M, Loewel H, Helbecque N, Woodward M, Amouyel P, et al. Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem. 2003 Apr; 49(4):669-72. doi: 10.1373/49.4.669 PMID: 12651827
9. Sørensen CJ, Pedersen OB, Petersen MS, Sørensen E, Kotze S, Thørner LW, et al. Combined oral contraception and obesity are strong predictors of low-grade inflammation in healthy individuals: results from the Danish Blood Donor Study (DBDS). PloS One. 2014;9(2):e88196. doi: 10.1371/journal.pone.0088196 PMID: 24516611
10. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012 Oct. 4;367(14):1310-20. doi: 10.1056/NEJMoa1107477 PMID: 23034020
11. Legouffe E, Rodriguez C, Picot MC, Richard B, Klein B, Rossi JF, et al. C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. Leuk Lymphoma. 1998 Oct; 31(3-4):351-7. doi: 10.3109/10428199809059228 PMID: 9869199
12. Cao Y, Shi Y, Chen J, Tan Y, Cai Y-C, Luo H, et al. Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2012 Aug; 33(4):1039-44. doi: 10.1007/s13277-012-0337-z PMID: 22328138
13. Villegas R, Xiang YB, Cai H, Elasy T, Cai Q, Zhang X, et al. Lifestyle determinants of C-reactive protein in middle-aged, urban Chinese men. Nutr Metab Cardiovasc Dis NMCD. 2012 Mar; 22(3):223-30. doi: 10.1016/j.numecd.2010.07.007 PMID: 21111583
14. Kaspersen KA, Pedersen OB, Petersen MS, Hjalgrim H, Rostgaard K, Møller BK, et al. Obesity and risk of infection: results from the Danish Blood Donor Study. Epidemiol Camb Mass. 2015 Jul; 26(4):580-9. doi: 10.1097/EDE.0000000000000301 PMID: 25978794
15. Zacho J, Benfield T, Tybjærg-Hansen A, Nordestgaard BG. Increased Baseline C-Reactive Protein Concentrations Are Associated with Increased Risk of Infections: Results from 2 Large Danish Population Cohorts. Clin Chem. 2016 Feb; 62(2):335-42. doi: 10.1373/clinchem.2015.249680 PMID: 26721294
16. Kuikka LK, Salminen S, Ouwehand A, Gueimonde M, Strandberg TE, Finne-Soveri UH, et al. Inflammation markers and malnutrition as risk factors for infections and impaired health-related quality of life among older nursing home residents. J Am Med Dir Assoc. 2009 Jun; 10(5):348-53. doi: 10.1016/j. jamda.2009.02.007 PMID: 19497548
17. Pfitzner T, Krocker D, Perka C, Matziolis G. [C-reactive protein. An independent risk factor for the development of infection after primary arthroplasty]. Orthop. 2008 Nov; 37(11):1116-20. doi: 10.1007/s00132-008-1342-1 PMID: 18813908
18. Kotze SR, Pedersen OB, Petersen MS, Sørensen E, Thørner LW, Sørensen CJ, et al. Predictors of hemoglobin in Danish blood donors: results from the Danish Blood Donor Study. Transfusion (Paris). 2015 Jun; 55(6):1303-11. doi: 10.1111/trf.13011 PMID: 25647099
19. Kotze SR, Pedersen OB, Petersen MS, Sørensen E, Thørner LW, Sørensen CJ, et al. Low-grade inflammation is associated with lower haemoglobin levels in healthy individuals: results from the Danish blood donor study. Vox Sang. 2016 Mar. 1;n/a-n/a. doi: 10.1111/vox.12396 PMID: 26950401
20. Rigas AS, Pedersen OB, Sørensen CJ, Sørensen E, Kotze SR, Petersen MS, et al. No association between iron status and self-reported health-related quality of life in 16, 375 Danish blood donors: results from the Danish Blood Donor Study. Transfusion (Paris). 2015 Jul; 55(7):1752-6. doi: 10.1111/trf.13085 PMID: 25851623
21. Rigas AS, Sørensen CJ, Pedersen OB, Petersen MS, Thørner LW, Kotze S, et al. Predictors of iron levels in 14, 737 Danish blood donors: results from the Danish Blood Donor Study. Transfusion (Paris). 2014 Mar; 54(3 Pt 2):789-96. doi: 10.1111/trf.12518 PMID: 24372094
22. Landspatientregisteret (LPR)-Sundhedsdatastyrelsen [Internet]. [cited 2016 Aug. 20]. Available: http://sundhedsdatastyrelsen. dk/da/registre-og-services/om-de-nationale-sundhedsregistre/sygedomme-laegemidler-og-behandlinger/landspatientregisteret
23. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011 Jul; 39(7 Suppl):30-3. doi: 10.1177/1403494811401482 PMID: 21775347
24. WHO, International Classification of Diseases [Internet]. WHO. [cited 2016 Aug. 20]. Available: http://www.who.int/classifications/icd/en
25. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011 Jul; 39(7 Suppl):38-41. doi: 10.1177/1403494810394717 PMID: 21775349
26. Lægehåndbogen [Internet]. [cited 2016 Aug. 20]. Available: https://www.sundhed.dk/sundhedsfaglig/laegehaandbogen
27. Vejledning i brug af antibiotika [Internet]. [cited 2016 Aug. 20]. Available: http://pro.medicin. dk/Specielleemner/Emner/318019
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681 (87) 90171-8 PMID: 3558716
29. Kornum JB, Nørgaard M, Dethlefsen C, Due KM, Thomsen RW, Tjønneland A, et al. Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J. 2010 Dec; 36(6):1330-6. doi: 10.1183/09031936.00184209 PMID: 20351023
30. Ording AG, Horvath-Puho E, Garne JP, Nystrom PW, Vyberg M, Sørensen HT, et al. Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a Danish population-based cohort study. BMJ Open. 2014;4(6):e005082. doi: 10.1136/bmjopen-2014-005082 PMID: 24902734
31. Kaspersen KA, Pedersen OB, Petersen MS, Hjalgrim H, Rostgaard K, Møller BK, et al. Obesity and risk of infection: results from the danish blood donor study. Epidemiol Camb Mass. 2015 Jul; 26(4):580-9. doi: 10.1097/EDE.0000000000000301 PMID: 25978794
32. Sørensen CJ, Pedersen OB, Petersen MS, Sørensen E, Kotze S, Thørner LW, et al. Combined Oral Contraception and Obesity Are Strong Predictors of Low-Grade Inflammation in Healthy Individuals: Results from the Danish Blood Donor Study (DBDS). PloS One. 2014;9(2):e88196. doi: 10.1371/journal.pone.0088196 PMID: 24516611
33. Rifai N, Ridker PM. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem. 2003 Apr; 49(4):666-9. doi: 10.1373/49.4.666 PMID: 12651826
34. Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med. 2000 Nov. 13;160(20):3082-8. doi: 10.1001/archinte.160.20.3082 PMID: 11074737
35. Dinh KM, Pedersen OB, Petersen MS, Sørensen E, Sørensen CJ, Kaspersen KA, et al. The impact of CCR5-A32 deletion on C-reactive protein levels and cardiovascular disease: Results from the Danish Blood Donor Study. Atherosclerosis. 2015 Sep; 242(1):222-5. doi: 10.1016/j.atherosclerosis.2015.07. 031 PMID: 26222902
36. Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014 Jul. 8; doi: 10.1530/JOE-14-0283 PMID: 25006217
37. Sun S, Ji Y, Kersten S, Qi L. Mechanisms of inflammatory responses in obese adipose tissue. Annu RevNutr. 2012 Aug. 21;32:261-86. doi: 10.1146/annurev-nutr-071811-150623 PMID: 22404118
38. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA J Am Med Assoc. 2001 Jul. 18;286(3):327-34. doi: 10. 1001/jama.286.3.327 PMID: 11466099
39. Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen T-P, Valkonen V-P, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004 Aug; 47(8):1403-10. doi: https://dx.doi.org/10.1007/s00125-004-1472-x PMID: 15309290
40. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006 Jan 16;97(2A):3A-11A. doi: 10.1016/j.amjcard.2005.11.010 PMID: 16442931
41. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA J Am Med Assoc. 2003 Apr. 9;289(14):1799-804. doi: 10.1001/jama.289.14.1799 PMID: 12684358
42. Muller LMAJ, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AIM, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005 Aug. 1;41(3):281-8. doi: 10.1086/431587 PMID: 16007521
43. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004 Nov. 8;164(20):2206-16. doi: 10.1001/archinte.164.20.2206 PMID: 15534156
44. de Ferranti S, Rifai N. C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin Chim Acta Int J Clin Chem. 2002 Mar; 317(1-2):1-15. doi: 10.1016/s0009-8981 (01) 00797-5 PMID: 11814453
45. Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449-90. doi: 10.2147/CLEP. S91125 PMID: 26604824